Cardinal Health Inc
- Industrie
- Pharmaceutical Distribution
- Bourse
- États-Unis
- Pays / Région
- USA
- Date d'introduction en bourse
- 31 décembre 1987
- Effectif
- 53 084
- Site web
- www.cardinalhealth.com
Fourchette de valorisation composite · prudent $130–$160 / raisonnable $175–$215 / optimiste $240–$300. À $229.35, Entre la fourchette raisonnable et la fourchette optimiste.
À la publication $200.68 (24 mai 2026)
Données EODHD, présentées dans la devise de reporting ; à titre indicatif uniquement, ne constitue pas un conseil en investissement.
Cardinal Health, Inc. operates as a healthcare services and products company in the United States and internationally. It operates in two segments: Pharmaceutical and Specialty Solutions, and Global Medical Products and Distribution. The company provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home. It distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products. The company also provides services to pharmaceutical manufacturers and healthcare providers for specialty pharmaceutical products; pharmacy management services to hospitals; operates pharmacies, including pharmacies in community health centers; and repackages generic pharmaceuticals and over-the-counter healthcare products. In addition, it manufactures, sources, and distributes Cardinal Health branded medical, surgical, and laboratory products and devices that include exam and surgical gloves; needles, syringe, and sharps disposals; compression, incontinence, nutritional delivery, and wound care products; single-use surgical drapes, gowns, and apparel products; fluid suction and collection systems; urology products; operating room supply products; and electrode product lines. Further, the company distributes a range of national brand products, including medical, surgical, and laboratory products; provides supply chain services and solutions to hospitals, ambulatory surgery centers, clinical laboratories, and other healthcare providers; and assembles and sells sterile and non-sterile procedure kits. Additionally, it manufactures, prepares, and delivers radiopharmaceuticals; and optimizes direct shipments through integrated technology solutions. The company was incorporated in 1979 and is headquartered in Dublin, Ohio.
Historique
Cardinal Health, Inc. was incorporated in 1979 and is headquartered in Dublin, Ohio, with its IPO dated December 31, 1987. In recent years it has expanded aggressively into specialty and at-home care through acquisitions: in FY2025 it completed ION (about $1.1 billion), GI Alliance (about $2.8 billion for an initial 73%), ADS (about $1.1 billion), and Urology America (about $0.4 billion), followed by Solaris Health (about $1.9 billion) in FY2026. To improve generic-drug sourcing it operates Red Oak Sourcing, a procurement joint venture with CVS whose agreement runs through June 2029.
Position dans le secteur
Cardinal Health is one of the "Big Three" U.S. pharmaceutical wholesale distributors, a sector where Cencora, Cardinal Health, and McKesson together account for over 90% of U.S. pharmaceutical wholesale distribution, with its main named competitors being McKesson and Cencora. It reports two segments, Pharmaceutical and Specialty Solutions and Global Medical Products and Distribution, plus nuclear and precision health, at-Home Solutions, and OptiFreight logistics as other operating segments. It distributes branded, generic, specialty, and OTC products and manufactures Cardinal Health-branded medical, surgical, and laboratory products. FY2025 revenue was about $222.6 billion and the company employs roughly 53,084 people.
Pas encore d'analyse sur cette valeur dans votre langue.